Page last updated: 2024-08-21

alpha-aminopyridine and Agnosia

alpha-aminopyridine has been researched along with Agnosia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Afshari, K; Ashraf-Ganjouei, A; Badripour, A; Bagheri, S; Dehpour, AR; Etemadi, A; Faghani, S; Golbakhsh, M; Haghighi, F; Khavandi, MM; Moradi, K; Nikbakhsh, R	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Agnosia

Article	Year
Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an alternative therapy. International immunopharmacology, 2020, Volume: 86 Topics: Agnosia; Aminopyridines; Animals; Benzamides; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Humans; Male; Microglia; Neurogenic Inflammation; Phosphodiesterase 4 Inhibitors; Rats; Spinal Cord; Spinal Cord Injuries; Tabes Dorsalis	2020

Article

Year

Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an alternative therapy.

International immunopharmacology, 2020, Volume: 86

Topics: Agnosia; Aminopyridines; Animals; Benzamides; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Humans; Male; Microglia; Neurogenic Inflammation; Phosphodiesterase 4 Inhibitors; Rats; Spinal Cord; Spinal Cord Injuries; Tabes Dorsalis

2020